ID
15381
Description
Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00055718
Link
https://clinicaltrials.gov/show/NCT00055718
Keywords
Versions (2)
- 5/29/16 5/29/16 -
- 5/29/16 5/29/16 -
Uploaded on
May 29, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Drug/Agent Toxicity by Tissue/Organ NCT00055718
Eligibility Drug/Agent Toxicity by Tissue/Organ NCT00055718
- StudyEvent: Eligibility
Description
Patient Caracteristics
Description
Disease Caracteristics
Description
Prior concurrent therapy
Description
biologic therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0005527
Description
chemotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0392920
Description
endocrine therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0279025
Description
radiotherapy
Data type
boolean
Alias
- UMLS CUI [1]
- C1522449
Description
surgery
Data type
boolean
Alias
- UMLS CUI [1]
- C0543467
Similar models
Eligibility Drug/Agent Toxicity by Tissue/Organ NCT00055718
- StudyEvent: Eligibility
C0023449 (UMLS CUI [1,2])
C0042679 (UMLS CUI [2])
C0032952 (UMLS CUI [3])
C0011777 (UMLS CUI [4])
C0000618 (UMLS CUI [5])